Loading ...

Promoting Tolerance to Peanut in High-Risk Children

(

LEAP

)

ITN Protocol #:

ITN032AD

Branded Name:

LEAP

ClinicalTrials.Gov ID:

NCT00329784

Treatment Protocol #:

Peanut Tolerance

Therapeutic Area:

Allergy & Asthma

Current Status:

Complete

Summary:

Induction of Tolerance through Early Introduction of Peanut in High-Risk Children

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Gideon Lack, MDg.lack@hspg.org.uk

Work: 

020 7390 8347

Protocol Chair

Don Whitehousedwhitehouse@immunetolerance.org

Work: 

415-353-4426

Protocol Chair

David Larsondlarson@immunetolerance.org

Work: 

(240) 235-6159

Protocol Chair

Noha Lim, PhDnlim@immunetolerance.org

Work: 

240-235-6151

Protocol Chair

Peter Sayrepsayre@immunetolerance.org

Work: 

415-353-4423

Protocol Chair

Joy LaurienzoJLaurienzo@niaid.nih.gov

Work: 

301-451-4415

Protocol Chair

Michelle Severmichelle_sever@rhoworld.com

Work: 

919-595-6382

Protocol Chair

Rizwan QureshiRizwan.qureshi@ppdi.com

Work: 

+44 161 761 4053